Clinical Trials Logo

Clinical Trial Summary

Uterine natural killer (uNK) cells have been implicated to play a role in female reproductive performance. Serval studies showed an increased uNK cell density in the endometrium of women with reproductive failure. In this study, we wish to investigate the density and clustering of four different immune cells.


Clinical Trial Description

Implantation is a process whereby the embryo attaches itself to the endometrium. In humans, the endometrium has a specific period of uterine receptivity, which occurs 5-7 days after ovulation and remains receptive for ~4 days (cycle days 20-24), when embryo implantation starts. Implantation failure refers to the failure of the embryo to reach a stage when intrauterine gestational sac is recognized by ultrasonography. It occurs when the embryo is abnormal or when endometrial function is impaired.

Uterine natural killer (uNK) cells have been implicated to play a role in female reproductive performance. They comprise 70-80% of the total leukocyte population in the endometrium during implantation and early pregnancy. Several studies showed an increased uNK cell density in the endometrium of women with reproductive failure. To better understand the contribution of various immune factors to endometrial function and future pregnancy, it is proposed to examine the major immune cells in the same specimen to measure the relative magnitude of the cell density changes and the degree of clustering between two immune cell types.

The aim of this study is to investigate the endometrial leucocytes profile around the time of embryo implantation. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04079959
Study type Observational
Source Chinese University of Hong Kong
Contact Wing Ching Cheung, PhD
Phone 85235051764
Email [email protected]
Status Recruiting
Phase
Start date September 15, 2019
Completion date December 31, 2023

See also
  Status Clinical Trial Phase
Completed NCT03284515 - Vaccination In Pregnancy Gene Signature: VIP Signature Study
Enrolling by invitation NCT04527926 - STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy N/A
Recruiting NCT04296396 - Opioid Prescription After Cesarean Trial Phase 3
Not yet recruiting NCT04960800 - Effect of a Specific Exercise Program During Pregnancy on Diastasis Recti Abdominis N/A
Completed NCT03188250 - Chama Cha MamaToto: a Pilot Study of Peer Support Groups in Kenya N/A
Recruiting NCT03671109 - Improving Maternal heAlth by Reducing Malaria in African HIV Women Phase 3
Recruiting NCT03855735 - Communication and Patient Safety in Gynecology and Obstetrics - Study Protocol of an Intervention Study N/A
Active, not recruiting NCT03679130 - FitMum: Fitness for Good Health of Mother and Child N/A
Completed NCT03687879 - Women's Evaluation of the Childbirth Experience: From Pregnancy to Postpartum
Recruiting NCT04568044 - Evaluation of Humoral Immunity Following COVID-19 in Pregnancy
Recruiting NCT04572178 - Cash Payment and Counseling During Pregnancy N/A
Recruiting NCT04326322 - Methionine Requirements During Healthy Human Pregnancy N/A
Terminated NCT03246919 - Ideal Time of Oxytocin Infusion During Cesarean Section Phase 4
Completed NCT04146025 - Nurtured in Nature N/A
Recruiting NCT04976465 - Treatment and Clinical Outcomes Among SLE Patients in Pregnancy
Recruiting NCT04918524 - The Clinical Features and Pregnancy Outcomes of CTD Patients
Not yet recruiting NCT04939012 - Repro Health, Implementation Patient-centered, Reproductive Planning Decision Support Tool (MyPath) N/A
Not yet recruiting NCT04925765 - Virtual Reality Biofeedback for Postpartum Anxiety and Depression N/A
Not yet recruiting NCT04978064 - E-health Psychological Intervention in Pregnant Women Exposed to Intimate Partner Violence (eIPV) N/A
Recruiting NCT04374773 - Effects of Pregnancy-associated Hormones on THC Metabolism in Women Phase 4